Simcere Pharmaceutical Group (NYSE:SCR)
| CAPS Rating |
|
|---|---|
| Open | $9.75 |
| Previous Close | $9.81 |
| Daily Range | $9.15 - $9.75 |
| 52-Week Range | $7.12 - $13.72 |
| Market Cap | $498.17M |
| P/E Ratio | 14.90 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 19,573 |
| Average Daily Volume | 0 |
SCR
VS S&P 500 (SPY)
How do you think SCR will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SCR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SCR News and Commentary
- January Up - Now There's a 92.3% Chance that 2012 Will be a Good Year – NASDAQ
- The 2 Best-Performing Sectors Over the Last Decade – The Motley Fool
- Bristol-Myers, Simcere Extend Ties - Analyst Blog – NASDAQ
- China's Landing: Will These Stocks Buck the Trend? – The Motley Fool
- Emerging Markets: Will These BRIC Stocks Beat Short-Term Uncertainty? – The Motley Fool
- Cubist Squares Well With These 2 Metrics – The Motley Fool
- 2 Positive Signs for Cubist Pharmaceuticals – The Motley Fool
- Simcere Pharmaceutical Shares Plunged: What You Need to Know – The Motley Fool
- Top Pharma Stocks That Hedge Funds Love – SeekingAlpha
- Lets show Scruffy some love. – Blog at The Motley Fool
- Revenues Rise at Simcere Pharmaceutical – SeekingAlpha
- Scruffys got an avatar. – Blog at The Motley Fool
- Teva Passes This Key Test – The Motley Fool
- Using cultural genocide to sell ... coupons? – Blog at The Motley Fool
- 15 Small Cap Stocks With Great Management Teams – SeekingAlpha
- Scruffy says mmmm-hmmmmm! for charity. – Blog at The Motley Fool
- What Did Scrooge Do for a Living? – Blog at The Motley Fool
- Simcere Pharmaceutical Group Shares Popped: What You Need to Know – The Motley Fool
- China Biotech Week in Review: Major Cross-Border Initiatives – SeekingAlpha
- BMS Partners With Simcere as Low-Cost Strategy to Advance Prospective Cancer Drug – SeekingAlpha
RSS Headlines
Fool UK
